AstraZeneca's Dr. Niko Andre Discusses Leukemia & Lymphoma Drug CALQUENCE | Interview

Join The Conversation! | https://trialsitenews.com/
Dr. Niko Andre, MD, PhD and Global Franchise Head of Hematology and Immuno Oncology at AstraZeneca discusses new clinical trial information for CALQUENCE, a drug used to treat Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL).

You can learn more about CALQUENCE here:
Link | https://www.calquence.com